Literature DB >> 11579014

Psychiatric comorbidity in pathological gamblers seeking treatment.

A Ibáñez1, C Blanco, E Donahue, H R Lesieur, I Pérez de Castro, J Fernández-Piqueras, J Sáiz-Ruiz.   

Abstract

OBJECTIVE: The authors' goal was to determine the frequency of psychiatric comorbidity among treatment-seeking pathological gamblers, compare the severity of gambling and psychological problems in gamblers with and without comorbid disorders, and investigate differences between gamblers with and without comorbid disorders in the dopamine D(2) receptor gene (DRD(2)).
METHOD: Sixty-nine pathological gamblers who consecutively applied to a specialized outpatient treatment program were evaluated with structured interviews, self-report questionnaires, and psychological scales and were genotyped for a DRD(2) polymorphism.
RESULTS: A comorbid psychiatric disorder was present in 43 (62.3%) of the gamblers. The most frequent diagnoses were personality disorders (N=29 [42.0%]), alcohol abuse or dependence (N=23 [33.3%]), and adjustment disorders (N=12 [17.4%]). Gamblers with comorbid psychiatric disorders had gambling scores and psychological scale scores indicating greater severity of gambling and psychopathology. Significant differences in DRD(2) allele distribution were found in gamblers with and without comorbid disorders.
CONCLUSIONS: Psychiatric comorbidity is common among pathological gamblers and is associated with greater severity of clinical problems. The DRD(2) gene could be a liability genetic factor for psychiatric comorbidity in pathological gambling.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11579014     DOI: 10.1176/ajp.158.10.1733

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  52 in total

1.  Clinical gender differences among adult pathological gamblers seeking treatment.

Authors:  Enrique Echeburúa; Itxaso González-Ortega; Paz de Corral; Rocío Polo-López
Journal:  J Gambl Stud       Date:  2011-06

Review 2.  Genetics of pathological gambling.

Authors:  Angela Ibáñez; Carlos Blanco; Ignacio Perez de Castro; Jose Fernandez-Piqueras; Jeronimo Sáiz-Ruiz
Journal:  J Gambl Stud       Date:  2003

Review 3.  A discounting framework for choice with delayed and probabilistic rewards.

Authors:  Leonard Green; Joel Myerson
Journal:  Psychol Bull       Date:  2004-09       Impact factor: 17.737

4.  Towards a comprehensive developmental model of pathological gambling.

Authors:  Carlos Blanco; Joan Hanania; Nancy M Petry; Melanie M Wall; Shuai Wang; Chelsea J Jin; Kenneth S Kendler
Journal:  Addiction       Date:  2015-06-06       Impact factor: 6.526

5.  After the ban of slot machines in Norway: a new group of treatment-seeking pathological gamblers?

Authors:  Eli Torild Hellandsjø Bu; Arvid Skutle
Journal:  J Gambl Stud       Date:  2013-03

6.  The Relationship Between Problem Gambling and Attention Deficit Hyperactivity Disorder.

Authors:  O R Waluk; G J Youssef; N A Dowling
Journal:  J Gambl Stud       Date:  2016-06

7.  Prevalence and predictors of pathological gambling: results from the St. Louis personality, health and lifestyle (SLPHL) study.

Authors:  Renee M Cunningham-Williams; Richard A Grucza; Linda B Cottler; Sharon B Womack; Samantha J Books; Thomas R Przybeck; Edward L Spitznagel; C Robert Cloninger
Journal:  J Psychiatr Res       Date:  2005-07       Impact factor: 4.791

Review 8.  A comment on the utility of prevalence estimates of pathological gambling.

Authors:  Blasé Gambino
Journal:  J Gambl Stud       Date:  2006

9.  Should pathological gambling and obesity be considered addictive disorders? A factor analytic study in a nationally representative sample.

Authors:  Carlos Blanco; María García-Anaya; Melanie Wall; José Carlos Pérez de Los Cobos; Ewelina Swierad; Shuai Wang; Nancy M Petry
Journal:  Drug Alcohol Depend       Date:  2015-02-25       Impact factor: 4.492

10.  Cognitive-behavioral therapy for pathological gambling: cultural considerations.

Authors:  Mayumi Okuda; Iván Balán; Nancy M Petry; Maria Oquendo; Carlos Blanco
Journal:  Am J Psychiatry       Date:  2009-12       Impact factor: 18.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.